483
Sanofi Winthrop IndustrieSanofi Winthrop Industrie – FDA 483, Sep 18, 2017
Record Details
An FDA inspection of Sanofi Pasteur S.A. in Marcy l'Etoile, France, a licensed biological manufacturer, revealed significant deficiencies across multiple critical areas. Issues included an inadequate stability program for rabies vaccine, failures in aseptic processing simulations, and untimely reporting of serious adverse events to VAERS. The firm also exhibited weaknesses in its CAPA system, OOS investigations, visual inspection program, process validation, and personnel gowning practices.
View Company Profile
ID · 6d998153-5531-4e1b-90d5-4124927dcb02
Other documents for Sanofi Winthrop Industrie
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.